Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0735-1097(03)00474-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome.
Acta Diabetol
March 2024
Department of Internal Medicine, Bursa Postgraduate Hospital, Bursa, Turkey.
Article Synopsis
- The study aimed to explore how the stress hyperglycemia ratio (SHR) impacts the no-reflow phenomenon (NRP) in patients with acute coronary syndrome (ACS) undergoing saphenous vein graft (SVG) procedures.
- Researchers analyzed data from 223 ACS patients, finding a significant correlation between higher SHR levels and increased rates of NRP, as well as identifying that older patients and those with a greater thrombus burden were more likely to develop NRP.
- The findings suggest that SHR is a reliable, non-invasive predictor of NRP in ACS patients during SVG interventions, highlighting the importance of managing glucose levels and thrombus burden in these cases.
Letter: The Importance of Stress Hyperglycemia for Poor Outcomes in ST Elevation Myocardial Infarction Patients.
Angiology
July 2023
Department of Cardiology, Health Sciences University, Dr Siyami Ersek Training and Research Hospital, Istanbul, Turkey.
Impact of Stress Hyperglycemia on the Timing of Complete Revascularization in Non-diabetes Patients with ST Elevation Myocardial Infarction and Multivessel Disease.
Angiology
July 2023
Department of Cardiology Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Stress hyperglycemia (SHG) is related to an increased risk of mortality in diabetic patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). However, data are limited in non-diabetic patients especially in patients with multivessel disease (MVD). In this retrospective study, 742 non-diabetic patients with STEMI and MVD were divided into SHG group and non-SHG group.
View Article and Find Full Text PDFBackground: Stress hyperglycemia is a common finding during acute myocardial infarction and associated with poor prognosis. To reduce the occurrence of no-reflow, prognostic factors must be identified before primary percutaneous coronary intervention (PPCI). Our objective was to investigate the impact of stress hyperglycemia in non-diabetic and diabetic patients on no-reflow phenomenon after PPCI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!